Skip to main content
. 2016 Jul 16;233:3341–3351. doi: 10.1007/s00213-016-4375-x

Fig. 1.

Fig. 1

Individual SDLP (cm) differences from placebo (mean and 90 % confidence interval) by treatment and day following bedtime administration of suvorexant (MK-4305) 15 mg, 30 mg single dose (day 2) and multiple doses (day 9), and single dose of zopiclone 7.5 mg (day 2 and day 9), n = 24